INMUNE BIO INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
INMUNE BIO INC. (INMB) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 100.00 thousand shares for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-07.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2025-08-07
- INMUNE BIO INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-06-30 was 0.00 shares.
- INMUNE BIO INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-03-31 was 100.00K shares.
- INMUNE BIO INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-12-31 was 1.13M shares.
- INMUNE BIO INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-09-30 was 36.50K shares.
- INMUNE BIO INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 1.96M shares, a 195.38% increase from fiscal 2023.
- INMUNE BIO INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 665.00K shares, a 18.80% decline from fiscal 2022.
- INMUNE BIO INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 819.00K shares, a 0.49% decline from fiscal 2021.
- INMUNE BIO INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2021 was 823.00K shares, a 1957.50% increase from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|---|
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | 100.00K shares 10-Q · filed 2025-08-07 | 1.23M shares derived: sum of 3 quarters · filed 2025-08-07 | 1.27M shares derived: sum of 4 quarters · filed 2025-08-07 | |
| 2025-03-31 | 100.00K shares 10-Q · filed 2025-05-08 | 1.23M shares derived: sum of 2 quarters · filed 2025-05-08 | 1.27M shares derived: sum of 3 quarters · filed 2025-05-08 | ||
| 2024-12-31 | 1.13M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | 1.17M shares derived: sum of 2 quarters · filed 2025-03-27 | 1.96M shares 10-K · filed 2025-03-27 | ||
| 2024-09-30 | 36.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | 832.31K shares 10-Q · filed 2024-10-31 | |||
| 2024-06-30 | 795.81K shares 10-Q · filed 2024-08-01 | ||||
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | 0.00 shares derived: sum of 2 quarters · filed 2025-03-27 | 60.00K shares derived: sum of 3 quarters · filed 2025-03-27 | 665.00K shares 10-K · filed 2025-03-27 | |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | 60.00K shares derived: sum of 2 quarters · filed 2023-11-01 | 665.00K shares 10-Q · filed 2023-11-01 | 665.00K shares derived: sum of 4 quarters · filed 2024-03-28 | |
| 2023-06-30 | 60.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | 665.00K shares 10-Q · filed 2023-08-07 | 665.00K shares derived: sum of 3 quarters · filed 2024-03-28 | 665.00K shares derived: sum of 4 quarters · filed 2024-03-28 | |
| 2023-03-31 | 605.00K shares 10-Q · filed 2023-05-03 | 605.00K shares derived: sum of 2 quarters · filed 2024-03-28 | 605.00K shares derived: sum of 3 quarters · filed 2024-03-28 | 635.00K shares derived: sum of 4 quarters · filed 2024-03-28 | |
| 2022-12-31 | 665.00K shares 10-K · filed 2024-03-28 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | 0.00 shares derived: sum of 2 quarters · filed 2024-03-28 | 30.00K shares derived: sum of 3 quarters · filed 2024-03-28 | 819.00K shares 10-K · filed 2024-03-28 |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | 30.00K shares derived: sum of 2 quarters · filed 2022-11-02 | 819.00K shares 10-Q · filed 2022-11-02 | 834.00K shares derived: sum of 4 quarters · filed 2023-03-02 | |
| 2022-06-30 | 30.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | 819.00K shares 10-Q · filed 2022-08-03 | 834.00K shares derived: sum of 3 quarters · filed 2023-03-02 | 1.21M shares derived: sum of 4 quarters · filed 2023-03-02 | |
| 2022-03-31 | 789.00K shares 10-Q · filed 2022-05-05 | 804.00K shares derived: sum of 2 quarters · filed 2023-03-02 | 1.18M shares derived: sum of 3 quarters · filed 2023-03-02 | 1.41M shares derived: sum of 4 quarters · filed 2023-03-02 | |
| 2021-12-31 | 15.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | 388.00K shares derived: sum of 2 quarters · filed 2023-03-02 | 624.45K shares derived: sum of 3 quarters · filed 2023-03-02 | 823.00K shares 10-K · filed 2023-03-02 | |
| 2021-09-30 | 373.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | 609.45K shares derived: sum of 2 quarters · filed 2021-11-03 | 808.00K shares 10-Q · filed 2021-11-03 | 808.00K shares derived: sum of 4 quarters · filed 2022-03-03 | |
| 2021-06-30 | 236.45K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | 435.00K shares 10-Q · filed 2021-08-04 | 435.00K shares derived: sum of 3 quarters · filed 2022-03-03 | ||
| 2021-03-31 | 198.55K shares 10-Q · filed 2021-05-05 | 198.55K shares derived: sum of 2 quarters · filed 2022-03-03 | |||
| 2020-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | 40.00K shares 10-K · filed 2022-03-03 | |||
| 2020-09-30 | 40.00K shares 10-Q · filed 2020-11-05 | ||||
| 2019-12-31 | 1.78M shares 10-K · filed 2021-03-04 | ||||
| 2019-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | 0.00 shares 10-Q · filed 2019-08-09 | |||
| 2019-03-31 | 0.00 shares 10-Q · filed 2019-05-15 | ||||
| 2018-12-31 | 1.63M shares 10-K · filed 2020-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |